-

PLNT Investor Alert: Levi & Korsinsky Investigates Planet Fitness, Inc. (PLNT) for Potential Securities Fraud

CFO Jay Stasz guided for 9%-10% EPS growth on February 24, 2026 -- the Company later disclosed additional operational and financial pressures affecting its 2026 outlook.

NEW YORK--(BUSINESS WIRE)--Investors in Planet Fitness, Inc. (NYSE: PLNT) suffered significant losses after the Company issued weaker-than-expected FY 2026 outlook, undermining management’s earlier projection of approximately 9%-10% EPS growth discussed by CFO Jay Stasz during the Company’s Q4 2025 earnings call. Shareholders who lost money on their Planet Fitness investment are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

On February 24, 2026, during Planet Fitness's Q4 2025 earnings call, CFO Jay Stasz told investors: "We expect adjusted diluted EPS to increase between 9% to 10%" for FY 2026. This is based on approximately 80 million adjusted diluted weighted average shares outstanding…and our plan to repurchase approximately $150 million worth of shares in 2026.” CEO Colleen Keating added: "Our strong 2025 performance is a direct result of our discipline and focus on our 4 strategic imperatives." The Company also guided for approximately 9% total revenue growth over 2025 and projected 150-160 equipment placements weighted toward the second half of the year.

When Planet Fitness later issued weaker FY 2026 earnings expectations -- far below the 9%-10% growth range previously communicated -- management cited an extended equipment-replacement cycle, the sale of eight corporate-owned clubs in California, a $400 million debt refinancing, and weather-related disruptions affecting approximately 2,000 clubs. The true impact of these factors had not been disclosed during the February 24 call.

If you purchased Planet Fitness shares and suffered a loss, click here to get more information about the investigation. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

Frequently Asked Questions About the PLNT Investigation

Q: Who is conducting the PLNT investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased PLNT securities. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Planet Fitness, Inc. made materially false or misleading statements regarding its FY 2026 earnings outlook, including the 9%-10% EPS growth guidance issued on February 24, 2026, and the Company adequately disclosed operational and financial headwinds to investors at that time.

Q: Who is eligible to participate in the PLNT investigation? A: Investors who purchased PLNT stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What do PLNT investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What does it cost me to participate? A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I already sold my PLNT shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought PLNT and sold at a loss may still participate in the investigation.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky

NYSE:PLNT

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky

SHAK Investor Alert: Levi & Korsinsky Investigates Shake Shack (SHAK) for Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--Shake Shack (NYSE: SHAK) lost approximately 9-10% of its value today after the company cut FY 2026 restaurant-level profit margin guidance from 23-23.5% to 22-23% and trimmed quarterly guidance from 24-24.5% to only 22-23%. Shareholders who lost money on SHAK are encouraged to submit their information immediately. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.On May 7, 2026 -- just 26 days before today'...

FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--Shareholders of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) saw the stock plunged roughly 50% on June 1, 2026, following disclosure of an FDA safety concerns related to the PRC2 inhibitor drug class. Those who lost money on FULC are encouraged to submit their information immediately. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The single-session collapse followed Fulcrum’s June 1, 2026 Form 8-K, which...

OCS Investor Alert: Levi & Korsinsky Investigates Oculis Holding AG (OCS) for Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--Shareholders of Oculis Holding AG (NASDAQ: OCS) lost nearly $7 per share, more than 23%, in a single trading session when the company disclosed that its Phase 3 DIAMOND-1 and DIAMOND-2 trials for OCS-01 failed to meet the primary endpoint -- mean change in best-corrected visual acuity at week 52 -- in diabetic macular edema. Oculis simultaneously announced it would not pursue an FDA filing for the DME indication. Investors who lost money on OCS are encouraged to submi...
Back to Newsroom